APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Devices Genotoxicity Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medical Devices Genotoxicity Testing Service Market Analysis and Forecast 2026-2032

16 April 2026187 pages

Choose your research edition.

Industry ResearchMedical Devices Genotoxicity Testing Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Devices Genotoxicity Testing Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Medical Devices Genotoxicity Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Devices Genotoxicity Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Medical Devices Genotoxicity Testing Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Medical Devices Genotoxicity Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Devices Genotoxicity Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Devices Genotoxicity Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Devices Genotoxicity Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Devices Genotoxicity Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Devices Genotoxicity Testing Service include TÜV SÜD, NAMSA, Eurofins Scientific, SGS SA, Nelson Labs, CD Bioarticle, UL Solutions, Measurlabs and STC Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Devices Genotoxicity Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Devices Genotoxicity Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Devices Genotoxicity Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Devices Genotoxicity Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Devices Genotoxicity Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Devices Genotoxicity Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Medical Devices Genotoxicity Testing Service Segment by Company

TÜV SÜD

NAMSA

Eurofins Scientific

SGS SA

Nelson Labs

CD Bioarticle

UL Solutions

Measurlabs

STC Group

STEMart

Porsolt

TheraIndx

GBA Group

Adita Biosys

Adgyl Lifesciences

Medical Devices Genotoxicity Testing Service Segment by Type

In Vitro Testing

In Vivo Testing

Medical Devices Genotoxicity Testing Service Segment by Application

Implantable Devices

Polymer Devices

Drug Coating/Combination Devices

Others

Medical Devices Genotoxicity Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Devices Genotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Devices Genotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Devices Genotoxicity Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Devices Genotoxicity Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Devices Genotoxicity Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Devices Genotoxicity Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In Vitro Testing Major Player Table 3. In Vivo Testing Major Player Table 4. Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Implantable Devices Major Player Table 6. Polymer Devices Major Player Table 7. Drug Coating/Combination Devices Major Player Table 8. Others Major Player Table 9. Medical Devices Genotoxicity Testing Service Industry Trends Table 10. Medical Devices Genotoxicity Testing Service Industry Drivers Table 11. Medical Devices Genotoxicity Testing Service Industry Opportunities and Challenges Table 12. Medical Devices Genotoxicity Testing Service Industry Restraints Table 13. Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Medical Devices Genotoxicity Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Medical Devices Genotoxicity Testing Service Market Share by Region (2021-2026) Table 16. Global Medical Devices Genotoxicity Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Medical Devices Genotoxicity Testing Service Market Share by Region (2027-2032) Table 18. Global Medical Devices Genotoxicity Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Players (2021-2026) Table 20. Global Medical Devices Genotoxicity Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Medical Devices Genotoxicity Testing Service Key Players Headquarters & Area Served Table 22. Global Medical Devices Genotoxicity Testing Service Players, Product Type & Application Table 23. Global Medical Devices Genotoxicity Testing Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Medical Devices Genotoxicity Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Medical Devices Genotoxicity Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Type (2021-2026) Table 30. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Type (2027-2032) Table 31. Global Medical Devices Genotoxicity Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Application (2021-2026) Table 35. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Application (2027-2032) Table 36. TÜV SÜD Company Information Table 37. TÜV SÜD Business Overview Table 38. TÜV SÜD Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio Table 40. TÜV SÜD Recent Development Table 41. NAMSA Company Information Table 42. NAMSA Business Overview Table 43. NAMSA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio Table 45. NAMSA Recent Development Table 46. Eurofins Scientific Company Information Table 47. Eurofins Scientific Business Overview Table 48. Eurofins Scientific Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio Table 50. Eurofins Scientific Recent Development Table 51. SGS SA Company Information Table 52. SGS SA Business Overview Table 53. SGS SA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio Table 55. SGS SA Recent Development Table 56. Nelson Labs Company Information Table 57. Nelson Labs Business Overview Table 58. Nelson Labs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio Table 60. Nelson Labs Recent Development Table 61. CD Bioarticle Company Information Table 62. CD Bioarticle Business Overview Table 63. CD Bioarticle Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio Table 65. CD Bioarticle Recent Development Table 66. UL Solutions Company Information Table 67. UL Solutions Business Overview Table 68. UL Solutions Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio Table 70. UL Solutions Recent Development Table 71. Measurlabs Company Information Table 72. Measurlabs Business Overview Table 73. Measurlabs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio Table 75. Measurlabs Recent Development Table 76. STC Group Company Information Table 77. STC Group Business Overview Table 78. STC Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. STC Group Medical Devices Genotoxicity Testing Service Product Portfolio Table 80. STC Group Recent Development Table 81. STEMart Company Information Table 82. STEMart Business Overview Table 83. STEMart Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. STEMart Medical Devices Genotoxicity Testing Service Product Portfolio Table 85. STEMart Recent Development Table 86. Porsolt Company Information Table 87. Porsolt Business Overview Table 88. Porsolt Medical Devices Genotoxicity Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio Table 90. Porsolt Recent Development Table 91. TheraIndx Company Information Table 92. TheraIndx Business Overview Table 93. TheraIndx Medical Devices Genotoxicity Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio Table 95. TheraIndx Recent Development Table 96. GBA Group Company Information Table 97. GBA Group Business Overview Table 98. GBA Group Medical Devices Genotoxicity Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio Table 100. GBA Group Recent Development Table 101. Adita Biosys Company Information Table 102. Adita Biosys Business Overview Table 103. Adita Biosys Medical Devices Genotoxicity Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio Table 105. Adita Biosys Recent Development Table 106. Adgyl Lifesciences Company Information Table 107. Adgyl Lifesciences Business Overview Table 108. Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio Table 110. Adgyl Lifesciences Recent Development Table 111. North America Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Medical Devices Genotoxicity Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Medical Devices Genotoxicity Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 125. China Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 126. China Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 127. China Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 128. China Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Medical Devices Genotoxicity Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Medical Devices Genotoxicity Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Medical Devices Genotoxicity Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Medical Devices Genotoxicity Testing Service Image Figure 2. Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Devices Genotoxicity Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. In Vitro Testing Image Figure 5. In Vivo Testing Image Figure 6. Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Medical Devices Genotoxicity Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Implantable Devices Image Figure 9. Polymer Devices Image Figure 10. Drug Coating/Combination Devices Image Figure 11. Others Image Figure 12. Global Medical Devices Genotoxicity Testing Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Medical Devices Genotoxicity Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Medical Devices Genotoxicity Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Medical Devices Genotoxicity Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Medical Devices Genotoxicity Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Devices Genotoxicity Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Type (2021-2032) Figure 20. Global Medical Devices Genotoxicity Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Application (2021-2032) Figure 23. North America Medical Devices Genotoxicity Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032) Figure 25. North America Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032) Figure 26. North America Medical Devices Genotoxicity Testing Service Revenue Share by Country (2021-2032) Figure 27. United States Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Medical Devices Genotoxicity Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032) Figure 32. Europe Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032) Figure 33. Europe Medical Devices Genotoxicity Testing Service Revenue Share by Country (2021-2032) Figure 34. Germany Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Medical Devices Genotoxicity Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032) Figure 44. China Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032) Figure 45. Asia Medical Devices Genotoxicity Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032) Figure 47. Asia Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032) Figure 48. Asia Medical Devices Genotoxicity Testing Service Revenue Share by Region (2021-2032) Figure 49. Japan Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Medical Devices Genotoxicity Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Medical Devices Genotoxicity Testing Service Revenue Share by Country (2021-2032) Figure 59. Brazil Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Medical Devices Genotoxicity Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Testing
  • In Vivo Testing
Applications
  • Implantable Devices
  • Polymer Devices
  • Drug Coating/Combination Devices
  • Others
Companies covered
  • TÜV SÜD
  • NAMSA
  • Eurofins Scientific
  • SGS SA
  • Nelson Labs
  • CD Bioarticle
  • UL Solutions
  • Measurlabs
  • STC Group
  • STEMart
  • Porsolt
  • TheraIndx
  • GBA Group
  • Adita Biosys
  • Adgyl Lifesciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Devices Genotoxicity Testing Service Market by Type
  3. 1.2.1 Global Medical Devices Genotoxicity Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro Testing
  5. 1.2.3 In Vivo Testing
  6. 1.3 Medical Devices Genotoxicity Testing Service Market by Application
  7. 1.3.1 Global Medical Devices Genotoxicity Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Implantable Devices
  9. 1.3.3 Polymer Devices
  10. 1.3.4 Drug Coating/Combination Devices
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Medical Devices Genotoxicity Testing Service Market Dynamics
  1. 2.1 Medical Devices Genotoxicity Testing Service Industry Trends
  2. 2.2 Medical Devices Genotoxicity Testing Service Industry Drivers
  3. 2.3 Medical Devices Genotoxicity Testing Service Industry Opportunities and Challenges
  4. 2.4 Medical Devices Genotoxicity Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Devices Genotoxicity Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Medical Devices Genotoxicity Testing Service Growth Trends by Region
  3. 3.2.1 Global Medical Devices Genotoxicity Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Devices Genotoxicity Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Devices Genotoxicity Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Devices Genotoxicity Testing Service Revenue by Players
  2. 4.1.1 Global Medical Devices Genotoxicity Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Devices Genotoxicity Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Devices Genotoxicity Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Devices Genotoxicity Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Medical Devices Genotoxicity Testing Service Players, Product Type & Application
  8. 4.5 Global Medical Devices Genotoxicity Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Devices Genotoxicity Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Medical Devices Genotoxicity Testing Service Tier 1, Tier 2, and Tier 3
5 Medical Devices Genotoxicity Testing Service Market Size by Type
  1. 5.1 Global Medical Devices Genotoxicity Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Type (2021-2032)
6 Medical Devices Genotoxicity Testing Service Market Size by Application
  1. 6.1 Global Medical Devices Genotoxicity Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 TÜV SÜD
  2. 7.1.1 TÜV SÜD Company Information
  3. 7.1.2 TÜV SÜD Business Overview
  4. 7.1.3 TÜV SÜD Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio
  6. 7.1.5 TÜV SÜD Recent Developments
  7. 7.2 NAMSA
  8. 7.2.1 NAMSA Company Information
  9. 7.2.2 NAMSA Business Overview
  10. 7.2.3 NAMSA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio
  12. 7.2.5 NAMSA Recent Developments
  13. 7.3 Eurofins Scientific
  14. 7.3.1 Eurofins Scientific Company Information
  15. 7.3.2 Eurofins Scientific Business Overview
  16. 7.3.3 Eurofins Scientific Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio
  18. 7.3.5 Eurofins Scientific Recent Developments
  19. 7.4 SGS SA
  20. 7.4.1 SGS SA Company Information
  21. 7.4.2 SGS SA Business Overview
  22. 7.4.3 SGS SA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio
  24. 7.4.5 SGS SA Recent Developments
  25. 7.5 Nelson Labs
  26. 7.5.1 Nelson Labs Company Information
  27. 7.5.2 Nelson Labs Business Overview
  28. 7.5.3 Nelson Labs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio
  30. 7.5.5 Nelson Labs Recent Developments
  31. 7.6 CD Bioarticle
  32. 7.6.1 CD Bioarticle Company Information
  33. 7.6.2 CD Bioarticle Business Overview
  34. 7.6.3 CD Bioarticle Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio
  36. 7.6.5 CD Bioarticle Recent Developments
  37. 7.7 UL Solutions
  38. 7.7.1 UL Solutions Company Information
  39. 7.7.2 UL Solutions Business Overview
  40. 7.7.3 UL Solutions Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio
  42. 7.7.5 UL Solutions Recent Developments
  43. 7.8 Measurlabs
  44. 7.8.1 Measurlabs Company Information
  45. 7.8.2 Measurlabs Business Overview
  46. 7.8.3 Measurlabs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio
  48. 7.8.5 Measurlabs Recent Developments
  49. 7.9 STC Group
  50. 7.9.1 STC Group Company Information
  51. 7.9.2 STC Group Business Overview
  52. 7.9.3 STC Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 STC Group Medical Devices Genotoxicity Testing Service Product Portfolio
  54. 7.9.5 STC Group Recent Developments
  55. 7.10 STEMart
  56. 7.10.1 STEMart Company Information
  57. 7.10.2 STEMart Business Overview
  58. 7.10.3 STEMart Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 STEMart Medical Devices Genotoxicity Testing Service Product Portfolio
  60. 7.10.5 STEMart Recent Developments
  61. 7.11 Porsolt
  62. 7.11.1 Porsolt Company Information
  63. 7.11.2 Porsolt Business Overview
  64. 7.11.3 Porsolt Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio
  66. 7.11.5 Porsolt Recent Developments
  67. 7.12 TheraIndx
  68. 7.12.1 TheraIndx Company Information
  69. 7.12.2 TheraIndx Business Overview
  70. 7.12.3 TheraIndx Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio
  72. 7.12.5 TheraIndx Recent Developments
  73. 7.13 GBA Group
  74. 7.13.1 GBA Group Company Information
  75. 7.13.2 GBA Group Business Overview
  76. 7.13.3 GBA Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio
  78. 7.13.5 GBA Group Recent Developments
  79. 7.14 Adita Biosys
  80. 7.14.1 Adita Biosys Company Information
  81. 7.14.2 Adita Biosys Business Overview
  82. 7.14.3 Adita Biosys Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio
  84. 7.14.5 Adita Biosys Recent Developments
  85. 7.15 Adgyl Lifesciences
  86. 7.15.1 Adgyl Lifesciences Company Information
  87. 7.15.2 Adgyl Lifesciences Business Overview
  88. 7.15.3 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio
  90. 7.15.5 Adgyl Lifesciences Recent Developments
8 North America
  1. 8.1 North America Medical Devices Genotoxicity Testing Service Revenue (2021-2032)
  2. 8.2 North America Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Devices Genotoxicity Testing Service Revenue by Country
  11. 8.6.1 North America Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Devices Genotoxicity Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Devices Genotoxicity Testing Service Revenue (2021-2032)
  2. 9.2 Europe Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Devices Genotoxicity Testing Service Revenue by Country
  11. 9.6.1 Europe Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Devices Genotoxicity Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Devices Genotoxicity Testing Service Revenue (2021-2032)
  2. 10.2 China Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Devices Genotoxicity Testing Service Revenue (2021-2032)
  2. 11.2 Asia Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Devices Genotoxicity Testing Service Revenue by Country
  11. 11.6.1 Asia Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Devices Genotoxicity Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Devices Genotoxicity Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Devices Genotoxicity Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Devices Genotoxicity Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country
  11. 12.6.1 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Devices Genotoxicity Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst